OPS
CRL icon

Orion Portfolio Solutions’s Charles River Laboratories CRL Stock Holding History

Orion Portfolio Solutions’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,390
Closed -$257K – 1898
2024
Q4 		$257K Sell
1,390
-1,847
-57% -$356K ﹤0.01% 1629
2024
Q3 		$638K Sell
3,237
-67
-2% -$13.9K 0.01% 1243
2024
Q2 		$683K Sell
3,304
-74
-2% -$16.8K 0.01% 1163
2024
Q1 		$915K Sell
3,378
-38
-1% -$9.07K 0.01% 1026
2023
Q4 		$775K Sell
3,416
-602
-15% -$118K 0.01% 1049
2023
Q3 		$787K Sell
4,018
-560
-12% -$115K 0.01% 1033
2023
Q2 		$963K Sell
4,578
-107
-2% -$21.3K 0.01% 970
2023
Q1 		$946K Buy
+4,685
New +$1.06M 0.01% 899
2020
Q3 		– Sell
-30
Closed -$5K – 754
2020
Q2 		$5K Sell
30
-24
-44% -$3.83K ﹤0.01% 1454
2020
Q1 		$7K Buy
54
+30
+125% +$4.5K ﹤0.01% 1182
2019
Q4 		$4K Buy
+24
New +$3.32K ﹤0.01% 1302

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Orion Portfolio Solutions's CRL Position: Q1 2025 in Review

Orion Portfolio Solutions sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 1,390 shares — an estimated $257K sold.

Orion Portfolio Solutions first reported a position in CRL in Q4 2019 and held it in 11 quarters. The position peaked at $963K in Q2 2023. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Orion Portfolio Solutions reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Orion Portfolio Solutions sold 1,390 Charles River Laboratories shares in Q1 2025, an estimated $257K.
  • Orion Portfolio Solutions first reported a position in Charles River Laboratories in Q4 2019 and held it in 11 quarters.
  • Orion Portfolio Solutions's Charles River Laboratories position peaked at $963K in Q2 2023.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.